Circle Medical
+40%
est. 2Y upside i
Modern primary care via video and in-person
Rank
#1169
Sector
Healthcare
Est. Liquidity
~2Y
Data Quality
Data: LowCircle Medical offers a compelling equity opportunity with a ~40% expected 2-year upside, driven by high growth and profitability.
Last updated: July 19, 2026
IPO window or acquisition by WELL Health drives multiple expansion to 6x. Projected revenue $203M yields exit value $1.22B, up 143.6% from estimated $500M entry.
Exit multiple converges to ~3.5x, in line with public comps. Exit value $710M yields 42.1% upside. Growth and profitability support valuation.
Competitive pressure from incumbents and fraud settlement compress multiple to 2x. Exit value $406M yields -18.8% return; preference stack negligible.
Preference Stack Risk
lowFunding Intensity
652%Total preferred stock ($6.52M) is 1.3% of estimated entry valuation, minimal overhang.
Dilution Risk
lowCompany is profitable and self-sustaining; no near-term fundraising expected.
Secondary Liquidity
noneNo secondary market activity reported; liquidity unlikely before exit event.
Questions to Ask at the Interview
Strategic questions based on Circle Medical's data — designed to show you've done your homework.
- 1
“How does Circle Medical plan to differentiate from incumbents like MDLive and Teladoc, given their resources?”
- 2
“What is the path to liquidity—IPO, acquisition by WELL Health, or secondary sale?”
- 3
“How does the recent fraud settlement impact the company's insurance contracts and growth trajectory?”
Community
Valuation Sentiment
Our model estimates +40% upside. What do you think?
Anonymous. Do not share material non-public information.
Community Discussion
Comments are reviewed before they appear publicly.
Loading comments...
Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.